Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop

More than half of U.S. young adults have low ten-year but high lifetime risk of cardiovascular disease (CVD). Improving primary prevention in young adulthood may help reduce persistent CVD disparities and overall CVD morbidity and mortality. The National Heart, Lung, and Blood Institute (NHLBI) conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Navar, Ann Marie, Fine, Lawrence J., Ambrosius, Walter T., Brown, Arleen, Douglas, Pamela S., Johnson, Karen, Khera, Amit V., Lloyd-Jones, Donald, Michos, Erin D., Mujahid, Mahasin, Muñoz, Daniel, Nasir, Khurram, Redmond, Nicole, Ridker, Paul M, Robinson, Jennifer, Schopfer, David, Tate, Deborah F., Lewis, Cora E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691440/
https://www.ncbi.nlm.nih.gov/pubmed/36439649
http://dx.doi.org/10.1016/j.ajpc.2022.100430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691440/
https://www.ncbi.nlm.nih.gov/pubmed/36439649
http://dx.doi.org/10.1016/j.ajpc.2022.100430

Ejemplares similares